Results 121 to 130 of about 2,799 (186)

An Organoid Model for the Therapeutic Effect of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. [PDF]

open access: yesAnn Surg Oncol
Liu D   +10 more
europepmc   +1 more source

Mini-review and situation report on the role and usefulness of nuclear medicine imaging for malaria. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Duvenhage J   +3 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Misonidazole neuropathy A prospective study

Journal of Neuro-Oncology, 1988
The frequency with which polyneuropathy developed was investigated in patients with cancer of the larynx and pharynx who participated in a double-blind trial of the radiosensitizing drug misonidazole. Fourteen of 36 patients receiving misonidazole (total dose of about 11 g/m2) developed neuropathy, while this occurred in only 2 of 34 patients in the ...
Jens Overgaard, O B Paulson
exaly   +5 more sources

Enhancement of artificial lung metastases by misonidazole

International Journal of Radiation Oncology Biology Physics, 1984
The effect of treatment with the hypoxic cell radiosensitizer misonidazole on the formation of artificial lung metastases was examined. Both single treatments with large doses of misonidazole and fractionated treatments with smaller doses of misonidazole were found to increase the number of lung tumors developing after intravenous injection of EMT6 ...
S, Rockwell, M, Nierenburg, C G, Irvin
exaly   +3 more sources

The effect of misonidazole on lymphocytes

The British Journal of Radiology, 1978
Misonidazole (Ro 07–0582) is a radiosensitizer of hypoxic cells (Denekamp and Harris, 1975). Early studies with radiotherapy patients have been encouraging (Thomlinson et al., 1976). However, peak plasma levels of 100 μg/ml in patients have been associated with neurotoxicity (Dische et al., 1977).
M G, Clare, C A, Joslin
openaire   +2 more sources

The pharmacokinetics of misonidazole in the dog

European Journal of Cancer (1965), 1979
Abstract The hypoxic cell radiosensitising drug misonidazole, [ 1 -( 2 -nitroimidazol- 1 -yl)- 3 -methoxypropan- 2 -ol, Ro 07-0582 ] was administered to dogs at dose levels of 50–200 mg/kg on four consecutive weekly occasions by oral and intravenous routes.
R A, White   +4 more
openaire   +2 more sources

Comparison of Binding of [ 3 H]Misonidazole and [ 14 C]Misonidazole in Multicell Spheroids

Radiation Research, 1985
Uptake of [2-ring-14C]misonidazole and [3H]misonidazole with tritium in the side chain has been compared in 1-mm EMT-6/UW spheroids using liquid scintillation counting and autoradiography. The uptake of both labeled sensitizers as a function of incubation time was virtually identical.
J S, Rasey   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy